APOB and myeloid sarcoma: Further, it is not known whether the associations between EL and apoB-containing lipoproteins are affected by metabolic syndrome (MS), a pathophysiological constellation characterized by central obesity, hypertension, hyperglycemia, and insulin resistance as well as dyslipidemia and upregulated EL [22,23].